Skip to main content
. 2012 Jun 5;7(6):e38787. doi: 10.1371/journal.pone.0038787

Figure 1. Effects of G1 on body weight, blood glucose, serum insulin and serum NO of diabetic OVX rats.

Figure 1

(A) Body weight was significantly decreased in OVX rats treated with STZ (n = 6) as compared with those in OVX rats (n = 20). G1 (200 µg/kg, i.p., 2 times per day, 8 weeks) administration (n = 6) attenuated the body weight loss in OVX rats treated with STZ. (B) Blood glucose was increased in OVX rats treated with STZ (n = 6) as compared with those in OVX rats (n = 20). G1 administration (n = 6) decreased the high blood glucose impairment in OVX rats treated with STZ. (C) The serum insulin levels had no difference among the four groups. (D) Diabetic OVX rats (n = 6) display a decrease in NO serum levels compared with those in OVX rats (n = 20). G1 administration (n = 6) increased NO serum levels compared with diabetic OVX rats. * p<0.05, ** p<0.01 compared with OVX rats; # p<0.05 compared with diabetic OVX rats.